1. Home
  2. JRVR vs BWAY Comparison

JRVR vs BWAY Comparison

Compare JRVR & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JRVR
  • BWAY
  • Stock Information
  • Founded
  • JRVR 2002
  • BWAY 2003
  • Country
  • JRVR Bermuda
  • BWAY Israel
  • Employees
  • JRVR N/A
  • BWAY N/A
  • Industry
  • JRVR Property-Casualty Insurers
  • BWAY Medical/Dental Instruments
  • Sector
  • JRVR Finance
  • BWAY Health Care
  • Exchange
  • JRVR Nasdaq
  • BWAY Nasdaq
  • Market Cap
  • JRVR 270.4M
  • BWAY 280.7M
  • IPO Year
  • JRVR 2005
  • BWAY 2019
  • Fundamental
  • Price
  • JRVR $5.62
  • BWAY $15.56
  • Analyst Decision
  • JRVR Buy
  • BWAY Strong Buy
  • Analyst Count
  • JRVR 4
  • BWAY 2
  • Target Price
  • JRVR $6.06
  • BWAY $18.00
  • AVG Volume (30 Days)
  • JRVR 317.1K
  • BWAY 90.5K
  • Earning Date
  • JRVR 08-04-2025
  • BWAY 08-13-2025
  • Dividend Yield
  • JRVR 0.71%
  • BWAY N/A
  • EPS Growth
  • JRVR N/A
  • BWAY 515.14
  • EPS
  • JRVR N/A
  • BWAY 0.11
  • Revenue
  • JRVR $665,342,000.00
  • BWAY $46,084,000.00
  • Revenue This Year
  • JRVR $2.19
  • BWAY $339.49
  • Revenue Next Year
  • JRVR $7.93
  • BWAY $21.74
  • P/E Ratio
  • JRVR N/A
  • BWAY $55.56
  • Revenue Growth
  • JRVR N/A
  • BWAY 26.50
  • 52 Week Low
  • JRVR $3.00
  • BWAY $7.06
  • 52 Week High
  • JRVR $7.69
  • BWAY $16.00
  • Technical
  • Relative Strength Index (RSI)
  • JRVR 46.47
  • BWAY 72.89
  • Support Level
  • JRVR $5.46
  • BWAY $14.70
  • Resistance Level
  • JRVR $5.82
  • BWAY $16.00
  • Average True Range (ATR)
  • JRVR 0.21
  • BWAY 0.64
  • MACD
  • JRVR -0.02
  • BWAY 0.18
  • Stochastic Oscillator
  • JRVR 25.81
  • BWAY 89.52

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure, and the Corporate and other segment consists of the management and treasury activities of holding companies, and equity compensation for the group.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: